In a Phase 1 trial, three once-monthly injections of 420 mg of maridebart cafraglutide in overweight/obese individuals without diabetes reduced body weight by 14%, and most of the weight loss was maintained for 23 months after treatment was discontinued [54]
When it comes to weight loss, this is O.K., since you were never supposed to stop eating altogether
This approach works well for researchers on established protocols who know their consumption rate and do not want to manage large upfront purchases
Liang XH, Shen W, Sun H, Migawa MT, Vickers TA, Crooke ST
How QuickMD can help The best time to take your GLP-1 injection depends on what feels right for your body and your schedule
Clinical attrition due to biased preclinical assessments of potential efficacy